From: FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
Parameter | Patients (N = 45) | |
---|---|---|
Mean (SD) age, years | 42.4 (12.15) | |
Gender | Male | 26 (58%) |
Female | 19 (42%) | |
Ethnicity | Caucasian | 6 (13%) |
African American | 18 (40%) | |
Asian | 18 (40%) | |
Hispanic | 1 (2%) | |
Indian | 2 (4%) | |
Grade | 0 | 4 (9%) |
1 | 20 (44%) | |
2 | 14 (31%) | |
3 | 6 (13%) | |
4 | 1 (2%) | |
Stage | 0 | 18 (40%) |
1 | 12 (27%) | |
2 | 8 (18%) | |
3 | 4 (9%) | |
4 | 3 (7%) | |
HIV co-infected | 12 (27%) | |
Mean ALT (U/L) (range) | 53 (10–240) | |
Mean AST (U/L) (range) | 46 (13–302) | |
Mean HBV DNA (IU/ml) (range) | 33,476,858 (<20-200,000,000) | |
Positive HBeAg | 19 (42%) |